A separate cohort of 553 NSCLC samples with matched tumor genomic profiling and PD-L1 expression on the same tissue at the DFCI was included in this analysis; their clinicopathologic characteristics are summarized in Supplementary Table 8. The gene discussed is CD274; the disease is neoplasm.